CANNABIS CULTURE – Mental Health Practitioners from TheraPsil, a Vancouver-based non-profit, have been approved by Health Canada to possess and use psilocybin for experiential training in delivering psilocybin-assisted therapy. The decision by Federal Health Minister Patty Hajdu comes just four months after TheraPsil successfully advocated for four terminally-ill patients to gain access to the psychedelic […]
Category Archives: Psychedelics
alternative medicine, anti-pharma, anti-pharmaceutical, Article, breakthrough therapy, CC Features, Headline News, Health Canada, MAPS, MDMA, MDMA-assisted therapy, Multidisciplinary Association for Psychedelic Studies, Newsletter, Numinus, psychedelic-assisted therapies, Psychedelics, PTSD
“Buried by Puppies Licking Your Face” (Canadian Firms Champion MDMA for PTSD)
CANNABIS CULTURE – Numinus Wellness Inc. and Multidisciplinary Association for Psychedelic Studies Public Benefit Corporation (MAPS PBC) have teamed up to petition Health Canada for approval to begin a trial using MDMA to treat PTSD. If approval is granted, this will be the first trial of its kind on Canadian soil. Numinus’ Vancouver clinic will host […]
CANNABIS CULTURE – According to Independent Consultant Mort Goldman, Pharm.D., “Ketamine is relatively short-acting, with an incredibly high level of safety. That’s why it’s a favorite among doctors as a procedural anesthetic.” That’s also why ketamine seems like one of the most reasonable solutions to treating mental and emotional distress in a time when few […]
CANNABIS CULTURE – Shared MDMA experiences are “like waking from a dream, and having something there to reassure you that not every part of the dream was fake,” says Psychedelic comedian, founder of Hello SciCom and emcee of the Listening to ecstasy Webinar — Sarah Rose Siskind.I signed up for this digital trip expecting to cover […]
CANNABIS CULTURE – “It is well understood that people with schizophrenia should not take large dosages of psychedelics because it is destabilizing,” says Mark Haden, Executive Director of the Multidisciplinary Association for Psychedelic Studies (MAPS) in Canada. “But we don’t know the effect of small dosages and how that can impact them.” The future of […]